Results of phase I/II trials with recombinant human interleukin-3

Biotechnol Ther. 1991;2(3-4):313-25.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Review

MeSH terms

  • Anemia, Aplastic / therapy
  • Animals
  • Bone Marrow Diseases / therapy
  • Drug Evaluation, Preclinical
  • Hematopoiesis / drug effects*
  • Humans
  • Interleukin-3 / adverse effects
  • Interleukin-3 / therapeutic use*
  • Myelodysplastic Syndromes / therapy
  • Neoplasms / therapy
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use

Substances

  • Interleukin-3
  • Recombinant Proteins